ArticleCancers2023
PARP1 Characterization as a Potential Biomarker for
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 3 citations in OpenAlex.
- Spectroscopic Signature of Apoptosis Induced by Venetoclax in Philadelphia-Positive Acute Lymphoblastic Leukemia.Analytical chemistry · 2026Article
- Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
- Biochemical Insights into the Effects of a Small Molecule Drug Candidate on Imatinib-Induced Cardiac Inflammation.International journal of molecular sciences · 2025Article
- Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes WithCancer diagnosis & prognosisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 7 institutions in 1 country.
Caio Bezerra MachadoDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.ORCID 0000-0001-8918-9812
Emerson Lucena da SilvaDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.ORCID 0000-0002-5761-8413
Wallax Augusto Silva FerreiraLaboratory of Cytogenomics and Environmental Mutagenesis, Environment Section (SAMAM), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.ORCID 0000-0002-9645-2292
Flávia Melo Cunha de Pinho PessoaDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
Andreza Urba de QuadrosCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Daianne Maciely Carvalho FantaciniCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Izadora Peter FurtadoCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Rafaela RossettiCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Roberta Maraninchi SilveiraCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Sarah Caroline Gomes de LimaCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Fernando Augusto Rodrigues Mello JúniorMolecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.
Aline Damasceno SeabraMolecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.
Edith Cibelle de Oliveira MoreiraInstitute of Health and Biological Studies, Federal University of the South and Southeast of Pará, Marabá 68501-970, PA, Brazil.
Manoel Odorico de Moraes FilhoDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
Maria Elisabete Amaral de MoraesDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
Raquel Carvalho MontenegroDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.
Rodrigo Monteiro RibeiroDepartment of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil.
André Salim KhayatDepartment of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.ORCID 0000-0002-3451-6369
Rommel Mário Rodriguez BurbanoMolecular Biology Laboratory, Ophir Loyola Hospital, Belém 66063-240, PA, Brazil.ORCID 0000-0002-4872-234X
Edivaldo Herculano Correa de OliveiraLaboratory of Cytogenomics and Environmental Mutagenesis, Environment Section (SAMAM), Evandro Chagas Institute (IEC), Ananindeua 67030-000, PA, Brazil.ORCID 0000-0001-6315-3352
Dimas Tadeu CovasCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.
Lucas Eduardo Botelho de SouzaCenter for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.ORCID 0000-0003-4254-7509
Caroline de Fátima Aquino Moreira-NunesDepartment of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.ORCID 0000-0001-5845-3481
Universidade de São Paulo · BRUniversidade Federal do Ceará · BRInstituto Evandro Chagas · BRUniversidade Federal do Pará · BRHospital Geral de Fortaleza · BRUniversidade Estadual do Ceará · BRUniversidade Federal do Sul e Sudeste do Pará · BR
Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.804627/2023-00National Council for Scientific and Technological Development 101375/2022-0National Council for Scientific and Technological Development 404213/2021-9São Paulo Research Foundation 2013/08135-2São Paulo Research Foundation 2020/02043-2São Paulo Research Foundation 2020/11413-8São Paulo Research Foundation 2021/09900-0São Paulo Research Foundation 22/09926-2
Abstract
Detection of t(9;22), and consequent
Indexed as
acute lymphoblastic leukemiadrug repositioningmolecular targeted therapypoly(ADP-ribose) polymerase inhibitors
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.